ATE520683T1 - Als inhibitoren von chemokinrezeptoren geeignete bipiperidinylderivate - Google Patents
Als inhibitoren von chemokinrezeptoren geeignete bipiperidinylderivateInfo
- Publication number
- ATE520683T1 ATE520683T1 AT04800524T AT04800524T ATE520683T1 AT E520683 T1 ATE520683 T1 AT E520683T1 AT 04800524 T AT04800524 T AT 04800524T AT 04800524 T AT04800524 T AT 04800524T AT E520683 T1 ATE520683 T1 AT E520683T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- chemokine receptors
- derivatives suitable
- bipiperidinyl derivatives
- bipiperidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51695403P | 2003-11-03 | 2003-11-03 | |
PCT/US2004/036273 WO2005042517A2 (en) | 2003-11-03 | 2004-11-01 | Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE520683T1 true ATE520683T1 (de) | 2011-09-15 |
Family
ID=34549586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04800524T ATE520683T1 (de) | 2003-11-03 | 2004-11-01 | Als inhibitoren von chemokinrezeptoren geeignete bipiperidinylderivate |
Country Status (14)
Country | Link |
---|---|
US (1) | US7652142B2 (de) |
EP (1) | EP1687295B1 (de) |
JP (2) | JP4757802B2 (de) |
KR (1) | KR20060100409A (de) |
CN (2) | CN101798299A (de) |
AR (1) | AR046923A1 (de) |
AT (1) | ATE520683T1 (de) |
AU (1) | AU2004285051A1 (de) |
CA (1) | CA2544377A1 (de) |
IL (1) | IL175331A0 (de) |
PE (1) | PE20050574A1 (de) |
TW (1) | TW200528445A (de) |
WO (1) | WO2005042517A2 (de) |
ZA (1) | ZA200603479B (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4948395B2 (ja) | 2004-04-13 | 2012-06-06 | インサイト・コーポレイション | ケモカインレセプターアンタゴニストとしてのピペラジニルピペリジン誘導体 |
US20080108586A1 (en) * | 2006-09-06 | 2008-05-08 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
US8119661B2 (en) | 2007-09-11 | 2012-02-21 | Astrazeneca Ab | Piperidine derivatives and their use as muscarinic receptor modulators |
EP3083594A1 (de) | 2013-12-19 | 2016-10-26 | Bayer Pharma Aktiengesellschaft | Substituierte bipiperidinyl-derivate als adrenorezeptor alpha 2c antagonisten |
AP2016009303A0 (en) | 2013-12-19 | 2016-06-30 | Bayer Pharma AG | Substituted piperidinyl-tetrahydroquinolines |
JOP20200052A1 (ar) | 2013-12-19 | 2017-06-16 | Bayer Pharma AG | بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c |
JP2017503778A (ja) | 2013-12-19 | 2017-02-02 | バイエル ファーマ アクチエンゲゼルシャフト | アドレナリン受容体α2C拮抗薬としての置換されたビピペリジニル誘導体 |
CN105456273A (zh) * | 2014-09-02 | 2016-04-06 | 杭州雷索药业有限公司 | 奈韦拉平在制备抗炎药物中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5368854A (en) | 1992-08-20 | 1994-11-29 | Schering Corporation | Use of IL-10 to treat inflammatory bowel disease |
IL117149A0 (en) | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
US5889006A (en) | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
US5952349A (en) | 1996-07-10 | 1999-09-14 | Schering Corporation | Muscarinic antagonists for treating memory loss |
US5977138A (en) | 1996-08-15 | 1999-11-02 | Schering Corporation | Ether muscarinic antagonists |
US6391865B1 (en) | 1999-05-04 | 2002-05-21 | Schering Corporation | Piperazine derivatives useful as CCR5 antagonists |
US6387930B1 (en) | 1999-05-04 | 2002-05-14 | Schering Corporation | Piperidine derivatives useful as CCR5 antagonists |
PL203116B1 (pl) | 1999-05-04 | 2009-08-31 | Schering Corp | Piperazynopiperydynowa pochodna użyteczna jako antagonista CCR5, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie |
KR100613528B1 (ko) * | 2001-03-29 | 2006-08-16 | 쉐링 코포레이션 | Ccr5 길항제, 및 이를 포함하는 약제학적 조성물 및 키트 |
GB0108876D0 (en) * | 2001-04-09 | 2001-05-30 | Novartis Ag | Organic Compounds |
AR036366A1 (es) | 2001-08-29 | 2004-09-01 | Schering Corp | Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit |
FR2835909B1 (fr) | 2002-02-12 | 2004-07-16 | Valeo Thermique Moteur Sa | Boite collectrice pour echangeur de chaleur, notamment pour un vehicule automobile |
-
2004
- 2004-11-01 US US10/979,075 patent/US7652142B2/en not_active Expired - Fee Related
- 2004-11-01 AU AU2004285051A patent/AU2004285051A1/en not_active Abandoned
- 2004-11-01 CN CN201010003780A patent/CN101798299A/zh active Pending
- 2004-11-01 JP JP2006538391A patent/JP4757802B2/ja not_active Expired - Fee Related
- 2004-11-01 KR KR1020067008532A patent/KR20060100409A/ko not_active Application Discontinuation
- 2004-11-01 CA CA002544377A patent/CA2544377A1/en not_active Abandoned
- 2004-11-01 CN CN2004800382299A patent/CN1898231B/zh not_active Expired - Fee Related
- 2004-11-01 AT AT04800524T patent/ATE520683T1/de not_active IP Right Cessation
- 2004-11-01 EP EP04800524A patent/EP1687295B1/de active Active
- 2004-11-01 WO PCT/US2004/036273 patent/WO2005042517A2/en active Application Filing
- 2004-11-02 PE PE2004001061A patent/PE20050574A1/es not_active Application Discontinuation
- 2004-11-02 AR ARP040104031A patent/AR046923A1/es not_active Application Discontinuation
- 2004-11-02 TW TW093133368A patent/TW200528445A/zh unknown
-
2006
- 2006-04-30 IL IL175331A patent/IL175331A0/en unknown
- 2006-05-02 ZA ZA200603479A patent/ZA200603479B/en unknown
-
2007
- 2007-10-11 JP JP2007265958A patent/JP2008031180A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ZA200603479B (en) | 2007-09-26 |
CA2544377A1 (en) | 2005-05-12 |
KR20060100409A (ko) | 2006-09-20 |
TW200528445A (en) | 2005-09-01 |
AR046923A1 (es) | 2006-01-04 |
US7652142B2 (en) | 2010-01-26 |
WO2005042517A3 (en) | 2005-07-28 |
CN101798299A (zh) | 2010-08-11 |
IL175331A0 (en) | 2006-09-05 |
WO2005042517A2 (en) | 2005-05-12 |
EP1687295A2 (de) | 2006-08-09 |
JP2008031180A (ja) | 2008-02-14 |
JP2007510653A (ja) | 2007-04-26 |
US20060025441A1 (en) | 2006-02-02 |
PE20050574A1 (es) | 2005-10-08 |
EP1687295B1 (de) | 2011-08-17 |
CN1898231A (zh) | 2007-01-17 |
AU2004285051A1 (en) | 2005-05-12 |
CN1898231B (zh) | 2010-10-27 |
JP4757802B2 (ja) | 2011-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004008303D1 (de) | Triazolopyrimidinderivate als inhibitoren von glycogensynthasekinase-3 | |
ATE452891T1 (de) | Pyrimidopyrimidone als kinaseinhibitoren | |
ATE538097T1 (de) | Als cox-i-inhibitoren geeignete pyrazolderivate | |
ATE404564T1 (de) | Diazepinoindolderivate als kinaseinhibitoren | |
DE602004025258D1 (de) | Aminotriazol-verbindungen als proteinkinase-hemmer | |
ATE437876T1 (de) | Hexahydropyridoisochinoline als dpp-iv- inhibitoren | |
ATE374201T1 (de) | 6-alkoxypyridopyrimidine als inhibitoren der p-38-map-kinase | |
DE60329282D1 (de) | Cyano-pyrrolidine als DPP-IV Inhibitoren | |
ATE478868T1 (de) | Pyrrolodihydroisochinoline als pde10- inhibitoren | |
DE60321324D1 (de) | Sulfonylaminoderivate als neue inhibitoren von histondeacetylase | |
ATE529421T1 (de) | Chinolinderivate als phosphodiesterase-hemmer | |
DK1562589T3 (da) | Diaminotriazoler der er nyttige som inhibitorer af proteinkinaser | |
ATE368651T1 (de) | Pyridazinon-derivate als gsk-3beta-hemmer | |
DK1534290T3 (da) | Hidtil ukendte kinasehæmmere | |
ATE402934T1 (de) | Malonamidderivate als gamma-secretaseinhibitoren | |
ATE400271T1 (de) | Aryl-pyridinderivate als 11-beta-hsd1-hemmer | |
ATE520671T1 (de) | Pyrimidin-harnstoff-derivate als kinase-hemmer | |
ATE521607T1 (de) | Piperidinderivate als renin-inhibitoren | |
DE60329529D1 (de) | Pyrazolderivate als faktor-xa-inhibitoren | |
ATE509011T1 (de) | Pyrimidinderivate als 11beta-hsd1-inhibitoren | |
ATE401328T1 (de) | Verbrückte n-arylsulfonylpiperidine als gamma- sekretaseinhibitoren | |
ATE419250T1 (de) | 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren | |
ATE529428T1 (de) | Thioxanthinderivate als myeloperoxidaseinhibitoren | |
ATE411306T1 (de) | Biarylsulfonamide als mmp-inhibitoren | |
DE60203529D1 (de) | Indolderivate als cox-ii-inhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |